Mason Street Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-139
| Closed | -$16K | – | 1525 |
|
|
2020
Q1 | $16K | Hold |
139
| – | – | ﹤0.01% | 1533 |
|
|
2019
Q4 | $34K | Buy |
139
+3
| +2% | +$734 | ﹤0.01% | 1518 |
|
|
2019
Q3 | $47K | Buy |
136
+25
| +23% | +$8.64K | ﹤0.01% | 1508 |
|
|
2019
Q2 | $102K | Buy |
111
+5
| +5% | +$4.6K | ﹤0.01% | 1466 |
|
|
2019
Q1 | $169K | Buy |
106
+4
| +4% | +$6.38K | ﹤0.01% | 1440 |
|
|
2018
Q4 | $191K | Buy |
102
+5
| +5% | +$9.36K | ﹤0.01% | 1337 |
|
|
2018
Q3 | $229K | Sell |
97
-16
| -14% | -$37.8K | ﹤0.01% | 1343 |
|
|
2018
Q2 | $390K | Buy |
113
+5
| +5% | +$17.3K | 0.01% | 1170 |
|
|
2018
Q1 | $308K | Buy |
108
+7
| +7% | +$20K | 0.01% | 1206 |
|
|
2017
Q4 | $261K | Buy |
101
+3
| +3% | +$7.75K | 0.01% | 1251 |
|
|
2017
Q3 | $279K | Buy |
98
+2
| +2% | +$5.69K | 0.01% | 1218 |
|
|
2017
Q2 | $227K | Buy |
96
+6
| +7% | +$14.2K | 0.01% | 1260 |
|
|
2017
Q1 | $228K | Buy |
90
+6
| +7% | +$15.2K | 0.01% | 1230 |
|
|
2016
Q4 | $189K | Buy |
84
+5
| +6% | +$11.3K | 0.01% | 1274 |
|
|
2016
Q3 | $198K | Buy |
79
+4
| +5% | +$10K | 0.01% | 1206 |
|
|
2016
Q2 | $230K | Buy |
75
+7
| +10% | +$21.5K | 0.01% | 1129 |
|
|
2016
Q1 | $215K | Buy |
68
+10
| +17% | +$31.6K | 0.01% | 1118 |
|
|
2015
Q4 | $298K | Buy |
58
+5
| +9% | +$25.7K | 0.01% | 988 |
|
|
2015
Q3 | $167K | Buy |
53
+4
| +8% | +$12.6K | 0.01% | 1136 |
|
|
2015
Q2 | $197K | Buy |
49
+2
| +4% | +$8.04K | 0.01% | 1090 |
|
|
2015
Q1 | $188K | Sell |
47
-929
| -95% | -$3.72M | 0.01% | 1105 |
|
|
2014
Q4 | $4.79M | Buy |
976
+268
| +38% | +$1.31M | 0.03% | 555 |
|
|
2014
Q3 | $2.88M | Sell |
708
-1
| -0.1% | -$4.07K | 0.02% | 773 |
|
|
2014
Q2 | $2.87M | Buy |
709
+2
| +0.3% | +$8.09K | 0.02% | 778 |
|
|
2014
Q1 | $3.22M | Sell |
707
-13
| -2% | -$59.1K | 0.03% | 717 |
|
|
2013
Q4 | $2.52M | Buy |
720
+5
| +0.7% | +$17.5K | 0.02% | 823 |
|
|
2013
Q3 | $2.94M | Buy |
715
+668
| +1,421% | +$2.75M | 0.03% | 527 |
|
|
2013
Q2 | $185K | Buy |
+47
| New | +$185K | ﹤0.01% | 1243 |
|